PMID- 35186289 OWN - NLM STAT- PubMed-not-MEDLINE LR - 20220223 IS - 2049-9361 (Print) IS - 2049-937X (Electronic) IS - 2049-9361 (Linking) VI - 9 DP - 2022 Jan-Dec TI - Children living with HIV: a narrative review of recent advances in pediatric HIV research and their implications for clinical practice. PG - 20499361221077544 LID - 10.1177/20499361221077544 [doi] LID - 20499361221077544 AB - Despite the great strides that have been made in prevention of mother to child transmission (PMTCT), children continue to acquire HIV. The reduction in transmission is variable, for example in Africa, great gains have been made in Eastern and Southern Africa, but critical gaps remain in West and Central Africa. These gaps are also observed in the treatment of children living with HIV. Although there is increased access to lifesaving antiretroviral therapy (ART), management of pediatric HIV infection continues to be a challenge to clinicians in low-income countries where the disease burden is disproportionately high. On the contrary, recent advances in ART drug types and formulations provide great hope. In this narrative review, we present key updates in HIV care and promising ART research among children and adolescents living with HIV. We particularly highlight the dolutegravir (DTG) research which informed the change of the World Health Organization (WHO) ART guidelines in this age group. Significant gaps remain around management of children presenting with advanced disease to minimize mortality and in the long-term care and treatment of adolescents living with HIV. Research to address these sensitive areas is crucial for the realization of global, regional, and national pediatric HIV targets. CI - (c) The Author(s), 2022. FAU - Nalwanga, Damalie AU - Nalwanga D AUID- ORCID: 0000-0002-1862-8109 AD - Department of Pediatrics and Child Health, Makerere University Lung Institute, P. O. Box 7072 Kampala, 256 Uganda. FAU - Musiime, Victor AU - Musiime V AD - Department of Pediatrics and Child Health, Makerere University, Kampala, Uganda; Joint Clinical Research Centre, Kampala, Uganda. LA - eng PT - Journal Article PT - Review DEP - 20220216 PL - England TA - Ther Adv Infect Dis JT - Therapeutic advances in infectious disease JID - 101606715 PMC - PMC8855388 OTO - NOTNLM OT - HIV infection in children OT - PMTCT OT - antiretroviral therapy COIS- Conflict of interest statement: The authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. EDAT- 2022/02/22 06:00 MHDA- 2022/02/22 06:01 PMCR- 2022/02/16 CRDT- 2022/02/21 06:03 PHST- 2021/10/01 00:00 [received] PHST- 2022/01/11 00:00 [accepted] PHST- 2022/02/21 06:03 [entrez] PHST- 2022/02/22 06:00 [pubmed] PHST- 2022/02/22 06:01 [medline] PHST- 2022/02/16 00:00 [pmc-release] AID - 10.1177_20499361221077544 [pii] AID - 10.1177/20499361221077544 [doi] PST - epublish SO - Ther Adv Infect Dis. 2022 Feb 16;9:20499361221077544. doi: 10.1177/20499361221077544. eCollection 2022 Jan-Dec.